Pharmacological properties of glutamatergic drugs targeting NMDA receptors and their application in major depression.
about
Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved TherapeuticsMolecular imaging for depressive disorders.Brain changes in early-onset bipolar and unipolar depressive disorders: a systematic review in children and adolescents.The role of ketamine in treatment-resistant depression: a systematic review.Behavioral deficits, abnormal corticosterone, and reduced prefrontal metabolites of adolescent rats subject to early life stress.NMDA Receptor Antagonists for Treatment of DepressionEffect of concomitant administration of three different antidepressants with vitamin B6 on depression and obsessive compulsive disorder in mice modelsLeading compounds for the validation of animal models of psychopathology.Novel glutamatergic drugs for the treatment of mood disorders.The involvement of microRNAs in major depression, suicidal behavior, and related disorders: a focus on miR-185 and miR-491-3p.NMDA antagonists under investigation for the treatment of major depressive disorder.Resilience dysregulation in major depressive disorder: focus on glutamatergic imbalance and microglial activation.What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.Ketamine decreases sensitivity of male rats to misleading negative feedback in a probabilistic reversal-learning task.MicroRNAs: fundamental regulators of gene expression in major affective disorders and suicidal behavior?Memantine for the Treatment of Dementia: A Review on its Current and Future Applications.Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study.Plasma amino acid profiling in major depressive disorder treated with selective serotonin reuptake inhibitors.Association of ARRB1 polymorphisms with the risk of major depressive disorder and with treatment response to mirtazapine.Structure-activity relationship study of spider polyamine toxins as inhibitors of ionotropic glutamate receptors.Neurotrophic, Cytoprotective, and Anti-inflammatory Effects of St. John's Wort Extract on Differentiated Mouse Hippocampal HT-22 Neurons.
P2860
Q26782997-50787BA7-B132-48BF-AA12-913557E78FF2Q30821361-7F5E40AE-3F89-417F-9B1D-AC28B94A1BC7Q34438081-3107FDEA-DDB2-4D22-AA70-5DD450796AC5Q34449588-9D3760D1-221B-4BBD-AF1B-6755C974309CQ36977035-A2A5457E-9EF0-48CC-9829-7F785215770AQ37277388-0735B6BB-AF71-4592-BF81-C425650113DCQ37676884-86480CF3-72D7-4062-8D8B-75385AFAF7ABQ38128733-F918767C-2391-43E0-B28D-944F74624A80Q38131480-A6D03FDF-3212-4675-9E44-F397BF1B5430Q38161385-813AADB8-58F2-4300-BFEF-452465167F9AQ38211107-A87FF6E8-7954-4DCC-AB80-4A78763A44A3Q38694251-105F08F1-6EB6-49AF-A4B7-7D8B5596A0AFQ39006234-D6C0718B-51F1-46B0-8FCD-B5FFA4A2E138Q41489870-E8E1E933-9340-4D75-B092-5F9EAFC9F7A5Q42047367-806B1DB8-336E-417F-9612-BDC4610E2630Q42270340-C8E90D0E-3E86-45B2-96E0-4E2FE71B30F8Q47280369-DE613BC2-CC0D-41A6-B12C-A38DC2D57E1BQ47889297-E38270FA-BC74-487D-A0ED-D370ADA4C8E2Q48130319-3A293BDF-D95B-4426-A24D-F9121EEDA224Q48196436-0CFCA687-110E-4F3B-A912-B96567504BA5Q48593466-C9F4B804-A0E3-44A2-A4CA-2DFC7FCED3E8Q49244418-51D3B27E-978B-469E-85D1-0F64C8FA7C82
P2860
Pharmacological properties of glutamatergic drugs targeting NMDA receptors and their application in major depression.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacological properties of ...... plication in major depression.
@en
type
label
Pharmacological properties of ...... plication in major depression.
@en
prefLabel
Pharmacological properties of ...... plication in major depression.
@en
P50
P1476
Pharmacological properties of ...... plication in major depression.
@en
P2093
Yogesh Dwivedi
P304
P356
10.2174/13816128113199990293
P577
2013-01-01T00:00:00Z